Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i> Mutant Pancreatic CancerCraig M. Goodwin, Channing J. Der, Valerie Calvert et al.|Cancer Research|2022Cited by 160
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant CancersIrem Ozkan‐Dagliyan, Channing J. Der, J. Nathaniel Diehl et al.|Cell Reports|2020Cited by 108
Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancerCraig M. Goodwin, Stephen W. Fesik|Cell Death and Differentiation|2015Cited by 107
Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell CarcinomaSehrish Javaid, Adrienne D. Cox, Antje Schaefer et al.|Molecular Cancer Therapeutics|2022Cited by 18
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.Mareen Lüthen, Sehrish Javaid, Jennifer E. Klomp et al.|UNC Libraries|2024Cited by 12